Effect of angiotensin-converting enzyme inhibitors on hematological parameters and recombinant human erythropoietin doses in peritoneal dialysis patients

被引：1
|
作者：
Navarro, JF [1 ]
Mora, C [1 ]
Rivero, A [1 ]
机构：
[1] Hosp Ntra Sra Candelaria, Dept Nephrol, E-38010 Santa Cruz De Tenerife, Spain
来源：
NEPHRON | 1998年 / 80卷 / 02期
关键词：
D O I：
10.1159/000045177
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：239 / 239
页数：1
相关论文
共 50 条
  • [1] Effects of angiotensin-converting enzyme inhibitors on anemia and erythropoietin requirements in peritoneal dialysis patients
    Navarro, JF
    Macia, ML
    Fernandez, CM
    Gallego, E
    Chahin, J
    Mendez, ML
    delCastillo, N
    Rivero, A
    Garcia, J
    [J]. ADVANCES IN PERITONEAL DIALYSIS/1997, VOL 13: SELECTED PAPERS FROM THE SEVENTEENTH ANNUAL CONFERENCE ON PERITONEAL DIALYSIS, DENVER, COLORADO, FEBRUARY 1997, 1997, 13 : 257 - 259
  • [2] Angiotensin-converting enzyme inhibitors are associated with the need for increased recombinant human erythropoietin maintenance doses in hemodialysis patients
    Matsumura, M
    Nomura, H
    Koni, I
    Mabuchi, H
    [J]. NEPHRON, 1997, 77 (02): : 164 - 168
  • [3] Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin therapy in chronic dialysis patients
    Charytan, C
    Goldfarb-Rumyantzev, A
    Wang, YF
    Schwenk, MH
    Spinowitz, BS
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1998, 18 (06) : 498 - 503
  • [4] Higher erythropoietin (EPO) requirements in peritoneal dialysis patients treated with angiotensin-converting enzyme inhibitors (ACEI).
    Navarro, JF
    Macia, M
    Mora, C
    Chahin, J
    Gallego, E
    Mendez, M
    Rivero, A
    Garcia, J
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1239 - A1239
  • [5] Unresponsiveness to recombinant human erythropoietin in haemodialysis patients: Possible implications of angiotensin-converting enzyme inhibitors
    Erturk, S
    Ates, K
    Duman, N
    Karatan, O
    Erbay, B
    Ertug, E
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (02) : 396 - 397
  • [6] Erythropoietin dose and angiotensin-converting enzyme inhibitors
    Grzegorzewska, A. E.
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2007, 27 (01): : 102 - 103
  • [7] Negative effect of angiotensin-converting enzyme inhibitors on erythropoietin response in CAPD patients
    Mora, C
    Navarro, JF
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2000, 20 (03) : 248 - 248
  • [8] The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients
    Basturk, Taner
    Unsal, Abdulkadir
    Koc, Yener
    Nezaket, Eren
    Ahbap, Elbis
    Sakaci, Tamer
    Sevinc, Mustafa
    [J]. CLINICS, 2012, 67 (08) : 877 - 883
  • [9] Lymphocyte subset counts in CAPD patients in relation to administration of recombinant human erythropoietin and angiotensin-converting enzyme inhibitors
    Grzegorzewska, AE
    Leander, M
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2002, 22 (05): : 625 - 628
  • [10] The effect of proinflammatory cytokine gene and angiotensin-converting enzyme polymorphisms on erythropoietin requirements in patients on continuous ambulatory peritoneal dialysis
    Sharples, EJ
    Varagunam, M
    Sinnott, PJ
    McCloskey, DJ
    Raftery, MJ
    Yaqoob, MM
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2006, 26 (01): : 64 - 68
12345